MedPath
HSA Approval

BICART POWDER FOR HAEMODIALYSIS

SIN06382P

BICART POWDER FOR HAEMODIALYSIS

BICART POWDER FOR HAEMODIALYSIS

July 3, 1991

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

POWDER, FOR SOLUTION

HEMODIALYSIS

Medical Information

B05ZA

血液透析

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Gambro Dasco S.p.A

Active Ingredients

SODIUM BICARBONATE

100%

Sodium bicarbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.